Breath Analyzer Market is Expected to Witness Rapid Growth of USD 1,167 million by 2025: MarketsandMarkets™

 According to the new market research report "Breath Analyzer Market by Technology (Fuel Cell, Semiconductor Oxide Sensor, Others), End User (Law Enforcement Agencies, Enterprises, Individuals), Application, Region (North America, Europe, APAC, RoW) - Global Forecast to 2025", published by MarketsandMarkets™, the market is expected to reach USD 1,167 million by 2025 from USD 524 million in 2020, at a CAGR of 17.4% during the forecast period. Growth in the market can primarily be attributed to factors such as alcohol and drug abuse, stringent government regulations and increasing use of breathalyzers in detecting various diseases.

  
Breath Analyzer Market

Browse in-depth TOC on " Breath Analyzer Market"

111- Tables

28- Figures

157- Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57484012

By technology, the fuel cell segment is expected to account for the largest share of the breath analzyer market in 2020

Based on technology, the breath analyzers market is segmented into fuel cells, semiconductor oxide sensors, and other technologies (infrared spectroscopy and chemical crystals). In 2020, the fuel cells segment accounted for the largest share of the global breath analyzers market. Fuel cells are the most widely used technology in breath analyzers. Fuel cell-based breath analyzers offer an extremely high level of accuracy, sensitivity, and reliability. They are specifically tuned to detect alcohol and do not require multiple sensors. These analyzers are considered the gold standard of handheld alcohol testers for both personal and professional use.

By application, the alcohol detection segment is expected to account for the largest share of the breath analyzer market in 2020

On the basis of application, the breath analyzers market is segmented into alcohol detection, drug abuse detection, and medical applications. The alcohol detection segment accounted for the largest market share in 2020. This segment is also projected to register the highest CAGR during the forecast period. The growth of this segment is primarily driven by stringent government regulations for driving under the influence (DUI).

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=57484012

By end user, the law enforcement agencies segment is expected to account for the largest share of the breath analzyer market in 2020

Based on end users, the breath analyzers market is segmented into law enforcement agencies, enterprises, and individuals. In 2020, the law enforcement agencies segment accounted for the largest share of the global breath analyzers market. Stringent safety laws against DUI and the rising scale of screening and evidential testing are driving the adoption of breath analyzers in law enforcement.

Asia-Pacific to witness the highest growth rate in 2020

Based on region, the breath analyzer market is segmented into North America, Asia-Pacific, Europe and Rest of the world(Row). Asia Pacific is expected to register the highest CAGR during the forecast period. The major factors driving the growth of the Asia Pacific market include as growing consumption of alcohol, increasing research on the medical applications of breath analyzers, and the development of advanced breath analyzers.

The prominent players in the global breath analyzer market include Drägerwerk AG & Co. KGaA (Germany), MPD, Inc (US), Lifeloc Technologies (US), BACtrack, Inc. (US), Quest Products, Inc. (US), Akers Biosciences, Inc. (US), Intoximeter, Inc. (US), AK GlobalTech Corporation (US), Alcohol Countermeasure Systems Corporation (Canada), EnviteC-Wismar GmbH (Germany), Lion Laboratories Ltd. (UK)

Speak to Analyst:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=57484012

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Related Reports:

Europe Fuel Cell Technology Market:

https://www.marketsandmarkets.com/Market-Reports/europe-fuel-cell-technology-market-1202.html

Allergy Diagnostics Market:

https://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html

Comments

Post a Comment

Popular posts from this blog

Healthcare Simulation Market Size & Share - Global Future Growth Predictions

Image
 The global healthcare simulation market is projected to reach USD 4.6 billion by 2028 from USD 2.2 billion in 2023, at a high CAGR of 15.7% during the forecast period. The expansion of this market is fueled by the increasing adoption of advanced techniques and methodologies in delivering medical education, along with restricted patient access during medical training. Nevertheless, the market's growth is anticipated to be somewhat hampered by the constrained availability of funds and incomplete replication of medical simulators. Market Size Introduction: The healthcare simulation market size represents the total valuation of products and services within the healthcare simulation industry over a specific period, typically a year. It encompasses various simulation technologies, including manikins, simulators, simulated environments, and software solutions, utilized for medical training, education, and research purposes. Understanding the market size is crucial for stakeholders as ...
Read more

Global Dental Practice Management Software Industry worth $2.3 billion By 2028

Image
 The Global Dental Practice Management Software Market in terms of revenue was estimated to be worth $1.5 billion in 2023 and is poised to reach $2.3 billion in 2028, growing at a CAGR of 8.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising awareness of oral hygiene and dental treatment, the increasing demand for advanced dental procedures, and the growing market for dental tourism in developing countries are major key drivers for the market. However, data privacy and security issues are the factors which may slow down market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153532396 Dental Practice Management Software Industry Dynamics Driver: Rising demand for advanced cosmetic dental procedures Cosmetic d...
Read more

Humanized Mouse and Rat Model Market worth $349 million by 2028

Image
  In the near future, the humanized mouse and rat model industry is set to undergo transformative advancements, revolutionizing biomedical research and drug development. These cutting-edge models, where mice and rats are genetically modified to possess human-like characteristics and immune systems, will play a pivotal role in bridging the gap between preclinical studies and clinical trials. Through refined genetic engineering techniques, these models will closely mimic human physiology, enabling more accurate and predictive assessments of drug safety, efficacy, and disease mechanisms. Moreover, the industry will witness the integration of advanced technologies, such as CRISPR/Cas9, to expedite the creation of customized humanized models, tailoring them to specific diseases or individual patient profiles. These advancements will spur collaboration between academia, pharmaceutical companies, and biotech firms, fostering a dynamic research ecosystem focused on targeted therapies and p...
Read more